ARTICLE | Company News
Alliance receives approvable letter
August 21, 2000 7:00 AM UTC
ALLP received from the FDA an approvable letter for its Imagent (AF0150) ultrasound contrast agent for endocardial border delineation, which was developed with partner Schering (Berlin, Germany). ALLP...